PR Newswire Clinical TrialsOriginal article
FastWave Medical Reports 96.4% Procedural Success in First-in-Human Study of Sola™ Coronary Laser IVL System
Phase 1positiveSola™ Coronary Laser IVL SystemPositive
AI Analysis
Summary
FastWave Medical reported positive first-in-human study results for its Sola™ Coronary Laser IVL System, achieving 96.4% procedural success with calcium fracture in all 30 treated lesions and 49% acute lumen gain prior to stenting.
Clinical Trial Data
Phase
first-in-human
Primary Endpoint
Met
Patients
30
Outcome Details
96.4% procedural success, calcium fracture in all treated lesions, 49% acute lumen gain prior to stenting
Importance:6/10
Sentiment:
0.80
intravascular lithotripsyIVLcoronary interventionmedical devicefirst-in-human studyfeasibility study
Read the original article
Published by PR Newswire Clinical Trials on September 29, 2026 12:36 PM